Guardant Health Inc [NASDAQ: GH] traded at a high on Thursday, posting a 13.05 gain after which it closed the day’ session at $28.59.
The results of the trading session contributed to over 5658658 shares changing hands. Over the past one week, the price volatility of Guardant Health Inc stands at 8.22% while the volatility over the past one month is 5.37%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for GH stock reached $3.52 billion, with 121.63 million shares outstanding and 117.72 million shares in the current float. Compared to the average trading volume of 2.13M shares, GH reached a trading volume of 5658658 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Guardant Health Inc [GH]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GH shares is $41.60 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GH stock is a recommendation set at 1.38. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for Guardant Health Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 28, 2024. While these analysts kept the previous recommendation, Jefferies raised their target price to Buy. The new note on the price target was released on June 03, 2024, representing the official price target for Guardant Health Inc stock. Previously, the target price had yet another raise to $28, while Craig Hallum analysts kept a Buy rating on GH stock.
The Average True Range (ATR) for Guardant Health Inc is set at 1.65, with the Price to Sales ratio for GH stock in the period of the last 12 months amounting to 5.08.
How has GH stock performed recently?
Guardant Health Inc [GH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 30.67. With this latest performance, GH shares gained by 36.86% in over the last four-week period, additionally plugging by 53.38% over the last 6 months – not to mention a rise of 3.06% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GH stock in for the last two-week period is set at 74.35, with the RSI for the last a single of trading hit 82.26, and the three-weeks RSI is set at 67.26 for Guardant Health Inc [GH]. The present Moving Average for the last 50 days of trading for this stock 23.08, while it was recorded at 24.80 for the last single week of trading, and 24.03 for the last 200 days.
Guardant Health Inc [GH]: Deeper insight into the fundamentals
Guardant Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.85 and a Current Ratio set at 6.22.
Earnings analysis for Guardant Health Inc [GH]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for GH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Guardant Health Inc go to 29.20%.
Insider trade positions for Guardant Health Inc [GH]
There are presently around $100.16%, or 104.97%% of GH stock, in the hands of institutional investors. The top three institutional holders of GH stocks are: VANGUARD GROUP INC with ownership of 11.64 million shares, which is approximately 9.5609%. BLACKROCK INC., holding 11.24 million shares of the stock with an approximate value of $$324.55 million in GH stocks shares; and BLACKROCK INC., currently with $$175.97 million in GH stock with ownership which is approximately 5.0063%.
